NO964871L - Nye agonistforbindelser - Google Patents
Nye agonistforbindelserInfo
- Publication number
- NO964871L NO964871L NO964871A NO964871A NO964871L NO 964871 L NO964871 L NO 964871L NO 964871 A NO964871 A NO 964871A NO 964871 A NO964871 A NO 964871A NO 964871 L NO964871 L NO 964871L
- Authority
- NO
- Norway
- Prior art keywords
- agonist compounds
- new agonist
- new
- compounds
- therapy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Nye morfinanderivater av formel (I). deres farmasøytisk akseptable salter, en fremgangsmåte for deres fremstilling og deres anvendelse i terapi.i
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9401727A SE9401727D0 (sv) | 1994-05-18 | 1994-05-18 | New compounds I |
PCT/SE1995/000504 WO1995031464A1 (en) | 1994-05-18 | 1995-05-09 | New agonist compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
NO964871L true NO964871L (no) | 1996-11-15 |
NO964871D0 NO964871D0 (no) | 1996-11-15 |
Family
ID=20394058
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO964871A NO964871D0 (no) | 1994-05-18 | 1996-11-15 | Nye agonistforbindelser |
Country Status (18)
Country | Link |
---|---|
US (1) | US5886001A (no) |
EP (1) | EP0759923A1 (no) |
JP (1) | JPH10500132A (no) |
CN (1) | CN1152314A (no) |
AU (1) | AU690281B2 (no) |
BR (1) | BR9507656A (no) |
CA (1) | CA2189139A1 (no) |
FI (1) | FI964576A0 (no) |
HU (1) | HU9603171D0 (no) |
IL (1) | IL113627A0 (no) |
IS (1) | IS4381A (no) |
NO (1) | NO964871D0 (no) |
NZ (1) | NZ287177A (no) |
PL (1) | PL317250A1 (no) |
SE (1) | SE9401727D0 (no) |
SK (1) | SK139696A3 (no) |
WO (1) | WO1995031464A1 (no) |
ZA (1) | ZA953699B (no) |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU712012B2 (en) * | 1995-09-26 | 1999-10-28 | Toray Industries, Inc. | Indole derivatives and medical application thereof |
CN1117754C (zh) * | 1997-01-16 | 2003-08-13 | 东丽株式会社 | 吲哚并吗啡喃衍生物及其组合物 |
GB9717629D0 (en) * | 1997-08-21 | 1997-10-22 | Johnson Matthey Plc | Removal of residual organic solvents |
WO2000008027A1 (en) * | 1998-08-06 | 2000-02-17 | Regents Of The University Of Minnesota | Kappa (op2) opioid receptor antagonists |
WO2002080919A1 (en) * | 2001-04-06 | 2002-10-17 | Regents Of The University Of Minnesota | Therapeutic compounds and methods |
US7232829B2 (en) | 2001-04-06 | 2007-06-19 | Regents Of The University Of Minnesota | Therapeutic compounds and methods |
DE10229842A1 (de) * | 2002-07-03 | 2004-02-05 | Helmut Prof. Dr. Schmidhammer | Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung |
NZ546834A (en) | 2003-10-01 | 2010-03-26 | Adolor Corp | Spirocyclic heterocyclic derivatives and methods of their use |
US7598261B2 (en) | 2005-03-31 | 2009-10-06 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
US7576207B2 (en) | 2006-04-06 | 2009-08-18 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
EP2399577A1 (en) | 2006-09-12 | 2011-12-28 | Adolor Corporation | Use of N-containing spirocompounds for the enhancement of cognitive function |
US9321116B2 (en) * | 2009-03-05 | 2016-04-26 | United Technologies Corporation | Cold metal transfer gas metal arc welding apparatus and method of operation |
EP2340832A1 (en) | 2009-12-23 | 2011-07-06 | Universität Innsbruck | Morphinan-6-one compounds for the treatment or prevention of neurodegenerative diseases |
JP6091426B2 (ja) * | 2010-12-23 | 2017-03-08 | フェニックス ファーマラブス インク | 鎮痛剤として有用な新規モルフィナン類 |
WO2014037832A2 (en) | 2012-09-06 | 2014-03-13 | Mahesh Kandula | Compositions and methods for the treatment of epilepsy and neurological diseases |
US9399634B2 (en) | 2012-05-07 | 2016-07-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of depression |
SG11201407300VA (en) | 2012-05-07 | 2014-12-30 | Cellix Bio Private Ltd | Compositions and methods for the treatment of neurological disorders |
WO2013168021A1 (en) | 2012-05-07 | 2013-11-14 | Mahesh Kandula | Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders |
WO2013168025A1 (en) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for treatment of blood clotting disorders |
WO2013168023A1 (en) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for treatment of parkinson's disease |
US9434704B2 (en) | 2012-05-08 | 2016-09-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological degenerative disorders |
WO2013167991A1 (en) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of metabolic disorders |
WO2013167992A1 (en) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of inflammatory disorders |
WO2013168016A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of metabolic syndrome |
US9315478B2 (en) | 2012-05-10 | 2016-04-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
WO2013168000A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of severe pain |
WO2013167999A2 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of neurologic diseases |
US9321775B2 (en) | 2012-05-10 | 2016-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of moderate to severe pain |
US9233161B2 (en) | 2012-05-10 | 2016-01-12 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological conditions |
US9339484B2 (en) | 2012-05-10 | 2016-05-17 | Cellix Bio Private Limited | Compositions and methods for the treatment of restless leg syndrome and fibromyalgia |
US9346742B2 (en) | 2012-05-10 | 2016-05-24 | Cellix Bio Private Limited | Compositions and methods for the treatment of fibromyalgia pain |
WO2013168014A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of familial amyloid polyneuropathy |
US9273061B2 (en) | 2012-05-10 | 2016-03-01 | Cellix Bio Private Limited | Compositions and methods for the treatment of chronic pain |
WO2013168015A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of asthma and allergy |
US9499526B2 (en) | 2012-05-10 | 2016-11-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurologic diseases |
WO2013168012A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of respiratory disorders |
WO2013175347A2 (en) | 2012-05-23 | 2013-11-28 | Mahesh Kandula | Compositions and methods for the treatment of respiratory disorders |
JP2015518854A (ja) | 2012-05-23 | 2015-07-06 | セリックスビオ プライヴェート リミテッド | 多発性硬化症の治療のための組成物および方法 |
WO2013175344A2 (en) | 2012-05-23 | 2013-11-28 | Mahesh Kandula | Compositions and methods for the treatment of periodontitis and rheumatoid arthritis |
US9765020B2 (en) | 2012-05-23 | 2017-09-19 | Cellix Bio Private Limited | Dichlorophenyl-imino compounds and compositions, and methods for the treatment of mucositis |
WO2013175376A2 (en) | 2012-05-23 | 2013-11-28 | Mahesh Kandula | Compositions and methods for the treatment of local pain |
CN104603100A (zh) | 2012-05-23 | 2015-05-06 | 塞利克斯比奥私人有限公司 | 用于治疗炎症性肠病的组合物和方法 |
US9108942B1 (en) | 2014-11-05 | 2015-08-18 | Mahesh Kandula | Compositions and methods for the treatment of moderate to severe pain |
WO2014020480A2 (en) | 2012-08-03 | 2014-02-06 | Mahesh Kandula | Compositions and methods for the treatment migraine and neurologic diseases |
US9624168B2 (en) | 2012-09-06 | 2017-04-18 | Cellix Bio Private Limited | Compositions and methods for the treatment inflammation and lipid disorders |
WO2014037834A2 (en) | 2012-09-08 | 2014-03-13 | Mahesh Kandula | Compositions and methods for the treatment of inflammation and lipid disorders |
HU231191B1 (hu) | 2013-04-15 | 2021-08-30 | Szegedi Tudományegyetem | Izotóp tartalmú morfin molekulák |
US9333187B1 (en) | 2013-05-15 | 2016-05-10 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory bowel disease |
CA2914461A1 (en) | 2013-06-04 | 2014-12-11 | Cellixbio Private Limited | Compositions and methods for the treatment of diabetes and pre-diabetes |
US9969746B2 (en) | 2013-12-05 | 2018-05-15 | The University Of Bath | Opioid compounds and their uses |
US9096537B1 (en) | 2014-12-31 | 2015-08-04 | Mahesh Kandula | Compositions and methods for the treatment of mucositis |
WO2016046835A1 (en) | 2014-09-26 | 2016-03-31 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy and neurological disorders |
CA2967908C (en) | 2014-09-29 | 2020-11-17 | Mahesh Kandula | Compositions and methods for the treatment of multiple sclerosis |
EP3212626B1 (en) | 2014-10-27 | 2018-11-07 | Cellix Bio Private Limited | Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis |
US9290486B1 (en) | 2014-11-05 | 2016-03-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy |
US9150557B1 (en) | 2014-11-05 | 2015-10-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of hyperglycemia |
US9284287B1 (en) | 2014-11-05 | 2016-03-15 | Cellix Bio Private Limited | Compositions and methods for the suppression of carbonic anhydrase activity |
US9321716B1 (en) | 2014-11-05 | 2016-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
US10208014B2 (en) | 2014-11-05 | 2019-02-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological disorders |
US9173877B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of local pain |
US9175008B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Prodrugs of anti-platelet agents |
US10034871B2 (en) | 2014-11-07 | 2018-07-31 | Regents Of The University Of Minnesota | Salts and compositions useful for treating disease |
US9932294B2 (en) | 2014-12-01 | 2018-04-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of multiple sclerosis |
US9206111B1 (en) | 2014-12-17 | 2015-12-08 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological diseases |
SG11201705524SA (en) | 2015-01-06 | 2017-08-30 | Cellix Bio Private Ltd | Compositions and methods for the treatment of inflammation and pain |
JP2019509321A (ja) | 2016-03-22 | 2019-04-04 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | 疼痛を処置するための組み合わせ |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816586A (en) * | 1987-07-29 | 1989-03-28 | Regents Of The University Of Minnesota | Delta opioid receptor antagonists |
JP2906654B2 (ja) * | 1989-11-28 | 1999-06-21 | 東レ株式会社 | 免疫抑制剤及びその製造方法 |
US5223507A (en) * | 1992-01-21 | 1993-06-29 | G. D. Searle & Co. | Method of using opioid compounds as delta opioid selective agonist analgesics |
US5225417A (en) * | 1992-01-21 | 1993-07-06 | G. D. Searle & Co. | Opioid agonist compounds |
ES2121988T3 (es) * | 1992-01-23 | 1998-12-16 | Toray Industries | Derivado de morfinano y uso medicinal. |
WO1994007896A1 (en) * | 1992-09-29 | 1994-04-14 | Toray Industries, Inc. | Indole derivative, process for producing the same, and medicinal use thereof |
US5464841A (en) * | 1993-11-08 | 1995-11-07 | Univ Minnesota | Use of delta opioid receptor antagonists to treat immunoregulatory disorders |
US5780479A (en) * | 1997-04-04 | 1998-07-14 | Regents Of The University Of Minnesota | Use of opioid antagonists to treat impulse-control disorders |
-
1994
- 1994-05-18 SE SE9401727A patent/SE9401727D0/xx unknown
-
1995
- 1995-05-07 IL IL11362795A patent/IL113627A0/xx unknown
- 1995-05-08 ZA ZA953699A patent/ZA953699B/xx unknown
- 1995-05-09 HU HU9603171A patent/HU9603171D0/hu unknown
- 1995-05-09 JP JP7529554A patent/JPH10500132A/ja not_active Abandoned
- 1995-05-09 US US08/507,365 patent/US5886001A/en not_active Expired - Fee Related
- 1995-05-09 NZ NZ287177A patent/NZ287177A/en unknown
- 1995-05-09 EP EP95920329A patent/EP0759923A1/en not_active Withdrawn
- 1995-05-09 PL PL95317250A patent/PL317250A1/xx unknown
- 1995-05-09 BR BR9507656A patent/BR9507656A/pt not_active Application Discontinuation
- 1995-05-09 WO PCT/SE1995/000504 patent/WO1995031464A1/en not_active Application Discontinuation
- 1995-05-09 CN CN95194032A patent/CN1152314A/zh active Pending
- 1995-05-09 AU AU25818/95A patent/AU690281B2/en not_active Ceased
- 1995-05-09 CA CA002189139A patent/CA2189139A1/en not_active Abandoned
- 1995-05-09 SK SK1396-96A patent/SK139696A3/sk unknown
-
1996
- 1996-11-08 IS IS4381A patent/IS4381A/is unknown
- 1996-11-15 NO NO964871A patent/NO964871D0/no not_active Application Discontinuation
- 1996-11-15 FI FI964576A patent/FI964576A0/fi unknown
Also Published As
Publication number | Publication date |
---|---|
EP0759923A1 (en) | 1997-03-05 |
CN1152314A (zh) | 1997-06-18 |
IS4381A (is) | 1996-11-08 |
BR9507656A (pt) | 1997-09-23 |
JPH10500132A (ja) | 1998-01-06 |
AU690281B2 (en) | 1998-04-23 |
SE9401727D0 (sv) | 1994-05-18 |
ZA953699B (en) | 1995-11-20 |
PL317250A1 (en) | 1997-04-01 |
SK139696A3 (en) | 1997-05-07 |
FI964576A (fi) | 1996-11-15 |
US5886001A (en) | 1999-03-23 |
WO1995031464A1 (en) | 1995-11-23 |
HU9603171D0 (en) | 1997-01-28 |
CA2189139A1 (en) | 1995-11-23 |
NO964871D0 (no) | 1996-11-15 |
FI964576A0 (fi) | 1996-11-15 |
AU2581895A (en) | 1995-12-05 |
IL113627A0 (en) | 1995-08-31 |
NZ287177A (en) | 1997-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO964871L (no) | Nye agonistforbindelser | |
NO904839L (no) | Fremgangsmaate for fremstilling av benzoxazinderivater. | |
TW332814B (en) | Morphinan derivative | |
GEP20043269B (en) | Purine Derivatives, Method for Their Production and Composition Containing the Same | |
AU2003301020A1 (en) | Isoquinolinone derivatives and their use as therapeutic agents | |
NO20023037L (no) | Nye piperidin- og piperazinderivater | |
MX9707453A (es) | Derivados de quinazolina. | |
FI925342A0 (fi) | Menetelmä terapeuttisesti aktiivisen (+)- -(2,3-dimetoksifenyyli)-1-/2-(4-fluorifenyyli)etyyli/-4-piperidiinimetanolin valmistamiseksi | |
GEP20053476B (en) | 3(5)-Amino-Pyrazole Derivatives, Process for Their Preparation and Their Use as Antitumor Agents | |
MY119150A (en) | Azetidine derivatives, their preparation and medicaments containing them | |
SE9401728D0 (sv) | New compounds II | |
NO996108L (no) | 9-oksinerytromycinderivater | |
NO963731L (no) | Behandling av obsessive-kompulsive sykdommer med 5HT2-antagonister | |
DK0960111T3 (da) | Morphinderivat med analgesisk aktivitet | |
MXPA04000407A (es) | Derivados de fenilacetamido-tiazol, procedimiento para su preparacion y uso como agentes antitumorales. | |
TR199700206A2 (xx) | Floralkil- ve floralkoksi ikame edilmi� heterosiklik bradikinin-antagonistleri, bunlar�n imal edilmesine mahsus usul ve bunlar�n kullan�lmalar�. | |
NO178858C (no) | Analogifremgangsmåte for fremstilling av substituerte 4-fenyl-4-piperidinkarboksamider med både lokal anestetisk og analgetisk effekt | |
NO20010654D0 (no) | Ny anvendelse av taxoidderivater | |
NO982863L (no) | Nye forbindelser med analgetisk effekt | |
TR199800478T1 (xx) | Diarilalkenilamin t�revleri | |
NO306718B1 (no) | Nye forbindelser med analgetisk og lokalanaestetisk effekt, farmasöytisk preparat inneholdende disse forbindelsene og deres anvendelse | |
AU1858992A (en) | 2-(1-piperidyl)ethanol derivatives, their preparation and their therapeutic application | |
NO913391L (no) | Fremgangsmaate for fremstilling av nye hetrazepinoide syreamider. | |
EE9400296A (et) | Piperidinüültioindooli derivaadid, ravimvormid, aktiivne valuvaigisti, nende valmistamise meetodid | |
MY133169A (en) | Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |